Irani J - Search Results

1

Can we improve the definition of high-risk, hormone naïve, non-metastatic prostate cancer?

Tombal B, Alcaraz A, James N, Valdagni R, Irani J. Tombal B, et al. Among authors: irani j. BJU Int. 2014 Feb;113(2):189-99. doi: 10.1111/bju.12469. BJU Int. 2014. PMID: 24112742 Review.

2

Fluctuating prostate-specific antigen levels in patients with initial negative biopsy: should we be reassured?

Celhay O, de la Taille A, Salomon L, Doré B, Irani J. Celhay O, et al. Among authors: irani j. BJU Int. 2007 May;99(5):1028-30. doi: 10.1111/j.1464-410X.2007.06752.x. Epub 2007 Feb 26. BJU Int. 2007. PMID: 17324221

3

Prostate cancer diagnosis in the new millennium: strengths and weaknesses of prostate-specific antigen and the discovery and clinical evaluation of prostate cancer gene 3 (PCA3).

Kirby RS, Fitzpatrick JM, Irani J. Kirby RS, et al. Among authors: irani j. BJU Int. 2009 Feb;103(4):441-5. doi: 10.1111/j.1464-410X.2008.08280.x. Epub 2009 Jan 9. BJU Int. 2009. PMID: 19154510 Review.

4

Testosterone measurement in patients with prostate cancer.

Schulman CC, Irani J, Morote J, Schalken JA, Montorsi F, Chlosta PL, Heidenreich A. Schulman CC, et al. Among authors: irani j. Eur Urol. 2010 Jul;58(1):65-74. doi: 10.1016/j.eururo.2010.04.001. Eur Urol. 2010. PMID: 20434831 Review.

5

The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significance.

van Poppel H, Haese A, Graefen M, de la Taille A, Irani J, de Reijke T, Remzi M, Marberger M. van Poppel H, et al. Among authors: irani j. BJU Int. 2012 Feb;109(3):360-6. doi: 10.1111/j.1464-410X.2011.10377.x. Epub 2011 Aug 26. BJU Int. 2012. PMID: 21883822

6

Is intermittent androgen-deprivation therapy beneficial for patients with advanced prostate cancer?

Wolff JM, Abrahamsson PA, Irani J, da Silva FC. Wolff JM, et al. Among authors: irani j. BJU Int. 2014 Oct;114(4):476-83. doi: 10.1111/bju.12626. Epub 2014 Apr 16. BJU Int. 2014. PMID: 24433259 Review.

7

The impact of re-transurethral resection on clinical outcomes in a large multicentre cohort of patients with T1 high-grade/Grade 3 bladder cancer treated with bacille Calmette-Guérin.

Gontero P, Sylvester R, Pisano F, Joniau S, Oderda M, Serretta V, Larré S, Di Stasi S, Van Rhijn B, Witjes AJ, Grotenhuis AJ, Colombo R, Briganti A, Babjuk M, Soukup V, Malmström PU, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha EK, Ardelt P, Vakarakis J, Bartoletti R, Dalbagni G, Shariat SF, Xylinas E, Karnes RJ, Palou J. Gontero P, et al. Among authors: irani j. BJU Int. 2016 Jul;118(1):44-52. doi: 10.1111/bju.13354. Epub 2015 Nov 6. BJU Int. 2016. PMID: 26469362 Free PMC article.

8

[Prostate cancer screening].

Villers A, Rébillard X, Soulié M, Davin JL, Coloby P, Moreau JL, Mejean A, Irani J, Coulange C, Mangin P; French Association of Urology. Villers A, et al. Among authors: irani j. Prog Urol. 2003 Apr;13(2):209-14. Prog Urol. 2003. PMID: 12765053 French.

9

Urinary/serum prostate-specific antigen ratio: comparison with free/total serum prostate-specific antigen ratio in improving prostate cancer detection.

Irani J, Salomon L, Soulié M, Zlotta A, de la Taille A, Doré B, Millet C. Irani J, et al. Urology. 2005 Mar;65(3):533-7. doi: 10.1016/j.urology.2004.10.003. Urology. 2005. PMID: 15780371

10

Effect of dutasteride on the symptoms of benign prostatic hyperplasia, and patient quality of life and discomfort, in clinical practice.

Desgrandchamps F, Droupy S, Irani J, Saussine C, Comenducci A. Desgrandchamps F, et al. Among authors: irani j. BJU Int. 2006 Jul;98(1):83-8. doi: 10.1111/j.1464-410X.2006.06241.x. BJU Int. 2006. PMID: 16831149 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

357 results

Search Page